Current stage?-Stage II - Page 10 of 30 Posts on Medivizor
Navigation Menu

Current stage?-Stage II Posts on Medivizor

The pre-operative use of accelerated partial breast irradiation in treating early-stage breast cancer

The pre-operative use of accelerated partial breast irradiation in treating early-stage breast cancer

Posted by on Apr 13, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated whether accelerated partial-breast irradiation (APBI) was useful for preoperative treatment of early-stage breast cancer (BC) patients. APBI was found to be an effective treatment option with good cosmetic results for certain early-stage BC patients. Some background Breast conserving therapy (surgery to remove...

Read More

The timing of first biopsy and its effect on prostate cancer reclassification

The timing of first biopsy and its effect on prostate cancer reclassification

Posted by on Apr 3, 2017 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the influence of biopsy timing on prostate cancer reclassification during active surveillance.  The authors concluded that the timing of the first biopsy was not related to an increased risk of cancer reclassification, but prostate specific antigen (PSA) and body mass index (BMI – measured based...

Read More

Smoking is associated with an increased risk of melanoma lymph node metastasis

Smoking is associated with an increased risk of melanoma lymph node metastasis

Posted by on Mar 20, 2017 in Melanoma | 0 comments

In a nutshell This study investigated the association between smoking and the risk of melanoma lymph node metastasis (LNM; spread to the lymph nodes). Researchers suggested that smoking is associated with an increase in the risk of LNM in melanoma patients. Some background Smoking is a well-known cause of cancer. However, it does not appear to be...

Read More

Chemotherapy after rectal cancer surgery is associated with improved survival

Chemotherapy after rectal cancer surgery is associated with improved survival

Posted by on Mar 13, 2017 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether chemotherapy after rectal surgery improves survival of rectal cancer patients. Researchers suggested that chemotherapy after rectal surgery is associated with improved survival.  Some background Rectal cancer affects almost 40,000 people annually in the United States. Roughly 50% of these patients...

Read More

Can sentinel lymph node dissection be used to identify patients who could benefit from further therapy?

Can sentinel lymph node dissection be used to identify patients who could benefit from further therapy?

Posted by on Mar 3, 2017 in Prostate cancer | 0 comments

In a nutshell The aim of the study was to examine if sentinel lymph node dissection (SLND) could be used to select patients with prostate cancer who would benefit from further pelvic radiation therapy and long-term androgen deprivation therapy (ADT). It was concluded that SLND could be used as a tool to determine whether patients should have more...

Read More

Relapse timing in stage 2 melanoma patients

Relapse timing in stage 2 melanoma patients

Posted by on Feb 6, 2017 in Melanoma | 0 comments

In a nutshell This study investigated the timing for relapse of stage 2 melanoma patients. Researchers suggested that patients with stage 2C melanomas are at higher risk of relapse and need a closer follow-up.   Some background Stage 2 melanoma patients can be divided in 3 different groups depending on specific factors such as tumor...

Read More

Surgery alone may not be enough in rectal cancer: Chemotherapy and radiation are associated with improved outcomes

Surgery alone may not be enough in rectal cancer: Chemotherapy and radiation are associated with improved outcomes

Posted by on Dec 19, 2016 in Colorectal cancer | 0 comments

In a nutshell This study investigated the outcomes of stage 3 rectal cancer patients with lymph node metastasis (cancer spread) who did not undergo chemotherapy and radiation (CRT) before surgery. Researchers suggested that these patients have worse outcomes when compared to patients who have undergone CRT.  Some background CRT followed by...

Read More

The role of active surveillance for men with intermediate-risk prostate cancer

The role of active surveillance for men with intermediate-risk prostate cancer

Posted by on Dec 19, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the role of active surveillance in the management of intermediate-risk prostate cancer. Researchers concluded that active surveillance is a safe management method for selected patients with favorable intermediate-risk disease. Men with more aggressive cancer cells may benefit from active treatment early on. Some...

Read More